Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma/delta T-cell lymphomas, Am J Pathol, vol.137, pp.617-628, 1990. ,
Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta, Blood, vol.75, pp.2213-2219, 1990. ,
Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin, Blood, vol.88, pp.4265-4274, 1996. ,
Hepatosplenic ???? T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients, Blood, vol.102, issue.13, pp.4261-4269, 2003. ,
DOI : 10.1182/blood-2003-05-1675
Hepatosplenic T Cell Lymphoma Associated With Infliximab Use in Young Patients Treated for Inflammatory Bowel Disease, Journal of Pediatric Gastroenterology and Nutrition, vol.44, issue.2, pp.265-267, 2007. ,
DOI : 10.1097/MPG.0b013e31802f6424
Paracortical Nodular T-Cell Lymphoma, The American Journal of Surgical Pathology, vol.19, issue.3, pp.297-303, 1995. ,
DOI : 10.1097/00000478-199503000-00007
Hepatosplenic ???? T-Cell Lymphoma, The American Journal of Surgical Pathology, vol.24, issue.7, pp.1027-1032, 2000. ,
DOI : 10.1097/00000478-200007000-00016
WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. IARC: Lyon, 2008. ,
Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: Isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression, Genes, Chromosomes and Cancer, vol.113, issue.10 suppl. 1, pp.243-251, 2002. ,
DOI : 10.1002/gcc.10021
Hepatosplenic T cell lymphoma responsive to 2???-deoxycoformycin therapy, American Journal of Hematology, vol.85, issue.9, pp.727-729, 2010. ,
DOI : 10.1002/ajh.21774
The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets, Blood. J Clin Invest, vol.109117, issue.12, pp.4952-4963823, 2007. ,
Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic ???? T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro, Leukemia, vol.2, issue.2, pp.348-358, 2011. ,
DOI : 10.1016/j.ceb.2006.08.016
Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type, Blood, vol.115, issue.6, pp.1226-1237, 2010. ,
DOI : 10.1182/blood-2009-05-221275
URL : https://hal.archives-ouvertes.fr/inserm-00462629
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma, Blood, vol.115, issue.5, pp.1026-1036, 2010. ,
DOI : 10.1182/blood-2009-06-227579
Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas, Oncogene, vol.89, issue.10, pp.1560-1570, 2006. ,
DOI : 10.1186/gb-2003-4-4-r28
Prognostic significance of a polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides Recombinative events of the T cell antigen receptor delta gene in peripheral T cell lymphomas Correia DV, d'Orey F, Cardoso BA, et al. Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk-and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells Aberrant expression of NK cell receptors in Epstein-Barr virus-positive gammadelta T-cell lymphoproliferative disorders, Blood. Blood. J Clin Invest. PLoS One. Hematology, vol.1139287415, issue.20, pp.1071-10743376, 1991. ,
Characterization of two novel cell lines ,
derived from a single patient with CD56+ non-Hodgkin's lymphoma Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma, Leukemia. Compagno M Nature, vol.15459, issue.23, pp.1641-1649717, 2001. ,
CXCR4 Expression Functionally Discriminates Centroblasts versus Centrocytes within Human Germinal Center B Cells, The Journal of Immunology, vol.182, issue.12, pp.7595-7602, 2009. ,
DOI : 10.4049/jimmunol.0804272
URL : https://hal.archives-ouvertes.fr/inserm-00869387
CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL Stimulated gammadelta T cells increase the in vivo efficacy of trastuzumab in HER-2+ breast cancer, J Immunol. J Immunol, vol.181187, pp.1031-1038, 2008. ,
T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow Isolation and characterization of genes associated with chromosome-6 mediated tumor suppression in human malignant melanoma, J Exp Med. Oncogene, vol.20612, issue.28, pp.2469-24812527, 1996. ,
PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor, Blood, vol.111, issue.7, pp.3867-3871, 2008. ,
DOI : 10.1182/blood-2007-08-108654
Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies, Leukemia, vol.2, issue.6, pp.1139-1151, 2009. ,
DOI : 10.1038/leu.2009.3
Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity, Int J Cancer. Leukemia. Blood, vol.12522101, issue.33, pp.1985-19911139, 2003. ,
NK-cell-associated receptor expression in hepatosplenic T-cell lymphoma, insights into pathogenesis The biology of NKT cells, Leukemia. Annu Rev Immunol, vol.2025, issue.35, pp.883-886297, 2006. ,
Infliximab induces clonal expansion of gammadelta- T cells in Crohn's disease: a predictor of lymphoma risk? PLoS One Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate, Science, vol.6316, pp.295-298, 2007. ,
Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor, Nature Immunology, vol.168, issue.12, pp.1337-1344, 2007. ,
DOI : 10.1038/ni1523
URL : https://hal.archives-ouvertes.fr/hal-00297257
Drug resistance in hematologic malignancies, Current Opinion in Oncology, vol.13, issue.6, pp.463-469, 2001. ,
DOI : 10.1097/00001622-200111000-00008
Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma, Blood, vol.109, issue.8, pp.3409-3416, 2007. ,
DOI : 10.1182/blood-2006-09-047621
Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type, American Journal of Hematology, vol.68, issue.10, pp.795-799, 2008. ,
DOI : 10.1002/ajh.21256
Effect of fludarabine and arabinosylcytosine on multidrug resistant cells, Haematologica, vol.82, pp.143-147, 1997. ,
Glutathione-Associated Enzymes In Anticancer Drug Resistance, Cancer Research, vol.76, issue.1, pp.4313-4320, 1994. ,
DOI : 10.1158/0008-5472.CAN-15-3143
Prognostic value of GST-?? expression in diffuse large B-cell lymphomas, Leukemia, vol.17, issue.5, pp.972-977, 2003. ,
DOI : 10.1038/sj.leu.2402930
High Level of Glutathione-S-Transferase ?? Expression in Mantle Cell Lymphomas, Clinical Cancer Research, vol.10, issue.9, pp.3029-3034, 2004. ,
DOI : 10.1158/1078-0432.CCR-03-0554
PRDM1 is a tumor suppressor gene in natural killer cell malignancies, Proceedings of the National Academy of Sciences, vol.108, issue.50, p.47, 2011. ,
DOI : 10.1073/pnas.1115128108
URL : https://hal.archives-ouvertes.fr/inserm-00656367
B cell antigen receptor-induced activation of Akt promotes B cell survival and is dependent on Syk kinase Spleen tyrosine kinase (Syk), a novel target of curcumin, is required for B lymphoma growth, J Immunol. J Immunol, vol.165178, issue.48, pp.1300-1306111, 2000. ,
Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines, Leukemia, vol.181, issue.1, pp.229-232, 2010. ,
DOI : 10.1158/0008-5472.CAN-07-0331
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia, Blood, vol.115, issue.13, pp.2578-2585, 2010. ,
DOI : 10.1182/blood-2009-08-236471